Full-Service Clinical Trials in Central and Eastern Europe

OCT is launching in Russia a phase II clinical trial in 130 metastatic breast cancer patients.

Phase I/II trial in solid tumors in 2 sites in Russia was approved.

Due to the slow recruitment in non- OCT countries, 6 new sites in Russia and 3 sites in Ukraine were opened in Phase III ovarian cancer trial in addition to 47 sites recruiting.

OCT started a new trial in orthopedic pain in 7 sites in Russia. The trial was transferred to OCT from another CRO.

OCT QA department starts 3d round of investigator GCP trainings for Novartis in September.

OCT started Phase IV trial in rhinitis in 8 sites in Russia.

OCT started a device trial in surgery in Baltic States

OCT started a phase III trial in mastocytosis in 11 sites in Russia, Bulgaria and Latvia

OCT started collaboration with RUSNANO

OCT started a phase IV pediatric trial in acute bronchitis in 12 sites in Russia

OCT started a phase III trial in endometrial cancer in 6 sites in Russia and Estonia. The study is to be launched also in Latvia, Lithuania and Czech Republic later in 2010.

OCT completed enrolment of 1223 patients in 11 sites across Russia in post- marketing study in pulmonology 1 month ahead.

OCT started phase III trial in breast cancer in 10 sites in Russia

OCT signed an exclusive collaboration agreement for providing regulatory support in Russia and Ukraine for a big pharmaceutical company.

OCT QA department starts investigator GCP training for Novartis in 7 cities across Russia.